Filing search / Madrigal Pharmaceuticals, Inc. / "Benefits" / Page 3

8-K

EX-99.1

9w2b4x qhi7c0bst4ade

8 Aug 23

Madrigal Pharmaceuticals Provides Corporate Updates and Reports Second Quarter 2023 Financial Results

8:00am

8-K

EX-99.1

0lzglx4k1um0y09

17 Jul 23

Other Events

8:00am

8-K

EX-99.1

qk3yfn6p

30 Jun 23

Madrigal expects to complete full submission of the New Drug Application in July 2023

8:00am

424B5

wybl2j0pn x1kr

9 May 23

Prospectus supplement for primary offering

9:02am

8-K

EX-99.1

uqm1s7i qqc

9 May 23

Madrigal Pharmaceuticals Provides Corporate Updates and Reports First Quarter 2023 Financial Results

8:00am

424B5

inlhoca

23 Dec 22

Prospectus supplement for primary offering

7:32am

8-K

9hlvvw5kru59r6

19 Dec 22

Regulation FD Disclosure

8:42am

8-K

EX-99.1

gxvga4pqtcsx

3 Nov 22

Presentations and Reports 2022 Third Quarter Financial Results

8:01am

8-K

EX-99.1

t6knr9s

4 Aug 22

Madrigal Pharmaceuticals Provides Clinical and Business Updates and Reports 2022 Second Quarter Financial Results

6:33am